145 related articles for article (PubMed ID: 32325133)
1. ETV5 overexpression contributes to tumor growth and progression of thyroid cancer through PIK3CA.
Meng D; Li Z; Ma X; Wu L; Fu L; Qin G
Life Sci; 2020 Jul; 253():117693. PubMed ID: 32325133
[TBL] [Abstract][Full Text] [Related]
2. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
[TBL] [Abstract][Full Text] [Related]
3. The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer Cells.
Puli OR; Danysh BP; McBeath E; Sinha DK; Hoang NM; Powell RT; Danysh HE; Cabanillas ME; Cote GJ; Hofmann MC
Neoplasia; 2018 Nov; 20(11):1121-1134. PubMed ID: 30265861
[TBL] [Abstract][Full Text] [Related]
4. ETV5 Silencing Produces Mesenchymal to Epithelial Transition in INS-1 (832/13) Cell Line.
Díaz-López YE; Cázares-Domínguez V; Arenas-Huertero F; Gutierrez-Aguilar R
Horm Metab Res; 2024 Mar; 56(3):235-243. PubMed ID: 38335994
[TBL] [Abstract][Full Text] [Related]
5. HPIP promotes thyroid cancer cell growth, migration and EMT through activating PI3K/AKT signaling pathway.
Wang SC; Chai DS; Chen CB; Wang ZY; Wang L
Biomed Pharmacother; 2015 Oct; 75():33-9. PubMed ID: 26463629
[TBL] [Abstract][Full Text] [Related]
6. E26 transformation (ETS)‑specific related transcription factor‑3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer.
Chen H; Chen W; Zhang X; Hu L; Tang G; Kong J; Wang Z
Oncol Rep; 2019 Jan; 41(1):570-578. PubMed ID: 30365150
[TBL] [Abstract][Full Text] [Related]
7. IQGAP1 modulates the proliferation and invasion of thyroid cancer cells in response to estrogen.
Meng D; Wu W; Li Z; Qin G
Int J Mol Med; 2015 Aug; 36(2):588-94. PubMed ID: 26046126
[TBL] [Abstract][Full Text] [Related]
8. IL13RA2 Is Differentially Regulated in Papillary Thyroid Carcinoma vs Follicular Thyroid Carcinoma.
Chong ST; Tan KM; Kok CYL; Guan SP; Lai SH; Lim C; Hu J; Sturgis C; Eng C; Lam PYP; Ngeow J
J Clin Endocrinol Metab; 2019 Nov; 104(11):5573-5584. PubMed ID: 31290966
[TBL] [Abstract][Full Text] [Related]
9. ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.
Llauradó M; Abal M; Castellví J; Cabrera S; Gil-Moreno A; Pérez-Benavente A; Colás E; Doll A; Dolcet X; Matias-Guiu X; Vazquez-Levin M; Reventós J; Ruiz A
Int J Cancer; 2012 Apr; 130(7):1532-43. PubMed ID: 21520040
[TBL] [Abstract][Full Text] [Related]
10. ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas.
Alonso-Alconada L; Eritja N; Muinelo-Romay L; Barbazan J; Lopez-Lopez R; Matias-Guiu X; Gil-Moreno A; Dolcet X; Abal M
Carcinogenesis; 2014 Dec; 35(12):2679-86. PubMed ID: 25233929
[TBL] [Abstract][Full Text] [Related]
11. Transcription factors TP63 facilitates malignant progression of thyroid cancer by upregulating KRT17 expression and inducing epithelial-mesenchymal transition.
Meng F; Dai L
Growth Factors; 2023 Oct; 41(2):71-81. PubMed ID: 36919456
[TBL] [Abstract][Full Text] [Related]
12. Atractylodes macrocephala III suppresses EMT in cervical cancer by regulating IGF2BP3 through ETV5.
Wang M; Meng J; Wang H; Hu H; Hong Y
J Cell Mol Med; 2024 Feb; 28(4):e18081. PubMed ID: 38358034
[TBL] [Abstract][Full Text] [Related]
13. ETV5 transcriptionally activates TGFβ1 and promotes cancer cell invasion and migration of NSCLC.
Li D; Shen Y; Ren H; Wang L; Yang J; Wang Y
J Mol Histol; 2023 Oct; 54(5):419-426. PubMed ID: 37656259
[TBL] [Abstract][Full Text] [Related]
14. ETS Factor ETV5 Activates the Mutant Telomerase Reverse Transcriptase Promoter in Thyroid Cancer.
Bullock M; Lim G; Zhu Y; Åberg H; Kurdyukov S; Clifton-Bligh R
Thyroid; 2019 Nov; 29(11):1623-1633. PubMed ID: 31452441
[No Abstract] [Full Text] [Related]
15. The role of E26 transformation-specific variant transcription factor 5 in colorectal cancer cell proliferation and cell cycle progression.
Peng Y; Feng H; Wang C; Song Z; Zhang Y; Liu K; Cheng X; Zhao R
Cell Death Dis; 2021 Apr; 12(5):427. PubMed ID: 33931578
[TBL] [Abstract][Full Text] [Related]
16. Two distinct E3 ligases, SCF
Liu J; Dong S; Wang H; Li L; Ye Q; Li Y; Miao J; Jhiang S; Zhao J; Zhao Y
FASEB J; 2019 Sep; 33(9):10538-10550. PubMed ID: 31238008
[TBL] [Abstract][Full Text] [Related]
17. Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion.
Pedrola N; Devis L; Llauradó M; Campoy I; Martinez-Garcia E; Garcia M; Muinelo-Romay L; Alonso-Alconada L; Abal M; Alameda F; Mancebo G; Carreras R; Castellví J; Cabrera S; Gil-Moreno A; Matias-Guiu X; Iovanna JL; Colas E; Reventós J; Ruiz A
Clin Exp Metastasis; 2015 Jun; 32(5):467-78. PubMed ID: 25924802
[TBL] [Abstract][Full Text] [Related]
18. Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARγ-SDF1/CXCR4 Signaling.
Zhou H; Xie X; Chen Y; Lin Y; Cai Z; Ding L; Wu Y; Peng Y; Tang S; Xu H
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556197
[TBL] [Abstract][Full Text] [Related]
19. Myeloid Zinc Finger 1 (MZF1) Maintains the Mesenchymal Phenotype by Down-regulating IGF1R/p38 MAPK/ERα Signaling Pathway in High-level MZF1-expressing TNBC cells.
Yue CH; Liu JY; Chi CS; Hu CW; Tan KT; Huang FM; Pan YR; Lin KI; Lee CJ
Anticancer Res; 2019 Aug; 39(8):4149-4164. PubMed ID: 31366500
[TBL] [Abstract][Full Text] [Related]
20. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
